Tuesday, July 02, 2019 11:17:30 AM
EVIO has accepted responsibility for this violation and resolved the issue with the Oregon Health Authority and its associated accreditation body, ORELAP. This was completed in October 2018 with the implementation of a corrective action plan. The corrective action plan included the termination of the employees involved in the incident, retraining of staff, and many improvements to company processes and software; all of which provide better monitoring of the company’s sampler activity.
The Company and EVIO Labs Portland have entered into a settlement agreement with the OLCC which reduced the penalty from the standard sanction of license cancellation to a 32-day suspension from testing cannabis products. The suspension will last from July 20, 2019 through August 21, 2019. During this timeframe, EVIO Labs Portland is permitted to continue serving its nationwide clients fulfilling their needs for testing hemp and CBD products. Furthermore, EVIO Labs continues to serve Oregon cannabis compliance customers from its Medford, Oregon location.
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM